Therapeutic targeting of 3′, 5′-cyclic nucleotide phosphodiesterases: inhibition and beyond

GS Baillie, GS Tejeda, MP Kelly - Nature reviews Drug discovery, 2019 - nature.com
Phosphodiesterases (PDEs), enzymes that degrade 3′, 5′-cyclic nucleotides, are being
pursued as therapeutic targets for several diseases, including those affecting the nervous …

The molecular biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors

D Paes, M Schepers, B Rombaut… - Pharmacological …, 2021 - Elsevier
Abstract The phosphodiesterase 4 (PDE4) enzyme family plays a pivotal role in regulating
levels of the second messenger cAMP. Consequently, PDE4 inhibitors have been …

TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination

Y Zhu, C Zhang, M Huang, J Lin, X Fan… - Frontiers in cell and …, 2021 - frontiersin.org
Hepatic stellate cells (HSCs) are activated by inflammatory mediators to secrete extracellular
matrix for collagen deposition, leading to liver fibrosis. Ferroptosis is iron-and lipid …

Nanodomain cAMP signalling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.

M Zaccolo, D Kovanich - Physiological reviews, 2024 - journals.physiology.org
3', 5'-cyclic adenosine monophosphate (cAMP) mediates the effects of sympathetic
stimulation on the rate and strength of cardiac contraction. Beyond this pivotal role, in …

Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression

L Yu, L Dong, Y Wang, L Liu, H Long, H Li, J Li, X Yang… - Cancer letters, 2019 - Elsevier
Upregulation of special AT-rich sequence-binding protein-1 (SATB1) has been suggested to
promote tumor growth and metastasis. However, the factors governing its cellular levels …

Pathogenesis of liver fibrosis and its TCM therapeutic perspectives

Y Nan, HC Su, XM Lian, J Wu, SJ Liu… - Evidence‐Based …, 2022 - Wiley Online Library
Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by
various pathogenic factors, which will further develop into cirrhosis or even hepatocellular …

The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis

S Jeon, H Jin, JM Kim, Y Hur, EJ Song, YJ Lee… - Journal of Biomedical …, 2023 - Springer
Background Heat shock protein 27 (HSP27) is overexpressed during pulmonary fibrosis
(PF) and exacerbates PF; however, the upregulation of HSP27 during PF and the …

Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial …

D Kim, GY Nam, E Seo, HS Jun - Journal of Biomedical Science, 2022 - Springer
Background Mesangial cell fibrosis, a typical symptom of diabetic nephropathy (DN), is a
major contributor to glomerulosclerosis. We previously reported that the pharmacological …

cAMP signaling in pathobiology of alcohol associated liver disease

M Elnagdy, S Barve, C McClain, L Gobejishvili - Biomolecules, 2020 - mdpi.com
The importance of cyclic adenosine monophosphate (cAMP) in cellular responses to
extracellular signals is well established. Many years after discovery, our understanding of …

TTC3 contributes to TGF-β1-induced epithelial−mesenchymal transition and myofibroblast differentiation, potentially through SMURF2 ubiquitylation and degradation

JH Kim, S Ham, Y Lee, GY Suh, YS Lee - Cell Death & Disease, 2019 - nature.com
Transforming growth factor-β (TGF-β) acts as a key cytokine in epithelial− mesenchymal
transition (EMT) and myofibroblast differentiation, which are important for normal tissue …